Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Barriers and Facilitators to the Implementation of first Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.

Wagner MS, Munro S, Wilcox ES, Devane C, Norman WV, Dunn S, Soon JA, Guilbert É.

J Obstet Gynaecol Can. 2020 Jan 8. pii: S1701-2163(19)30979-X. doi: 10.1016/j.jogc.2019.10.037. [Epub ahead of print]

PMID:
31924442
2.

Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma.

Mason R, Dearden HC, Nguyen B, Soon JA, Smith JL, Randhawa M, Mant A, Warburton L, Lo S, Meniawy T, Guminski A, Parente P, Ali S, Haydon A, Long GV, Carlino MS, Millward M, Atkinson VG, Menzies AM.

Pigment Cell Melanoma Res. 2019 Oct 6. doi: 10.1111/pcmr.12831. [Epub ahead of print]

PMID:
31587511
3.

Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.

Norman WV, Munro S, Brooks M, Devane C, Guilbert E, Renner R, Kendall T, Soon JA, Waddington A, Wagner MS, Dunn S.

BMJ Open. 2019 Apr 20;9(4):e028443. doi: 10.1136/bmjopen-2018-028443.

4.

Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.

Soon JA, Anton A, Torres J, Lawrence R, Parente P, McKendrick J, Davis ID, Pezaro C.

Support Care Cancer. 2019 Feb;27(2):373-382. doi: 10.1007/s00520-018-4492-7. Epub 2018 Oct 22.

PMID:
30350189
5.

Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.

Troskie C, Soon JA, Albert AY, Norman WV.

CMAJ Open. 2016 Nov 3;4(4):E654-E660. doi: 10.9778/cmajo.20160017. eCollection 2016 Oct-Dec.

7.

Requiring physicians to dispense mifepristone: an unnecessary limit on safety and access to medical abortion.

Norman WV, Soon JA.

CMAJ. 2016 Dec 6;188(17-18):E429-E430. doi: 10.1503/cmaj.160581. Epub 2016 Oct 17. No abstract available.

8.

Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview.

Soon JA, Costescu D, Guilbert E.

J Obstet Gynaecol Can. 2016 Jul;38(7):636-45. doi: 10.1016/j.jogc.2016.04.005. Epub 2016 May 14. Review.

PMID:
27591347
9.

Population-based evaluation of the effectiveness of two regimens for emergency contraception.

Leung VW, Soon JA, Lynd LD, Marra CA, Levine M.

Int J Gynaecol Obstet. 2016 Jun;133(3):342-6. doi: 10.1016/j.ijgo.2015.10.017. Epub 2016 Feb 24.

10.

The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study.

Norman WV, Soon JA, Panagiotoglou D, Albert A, Zed PJ.

Contraception. 2015 Jul;92(1):55-61. doi: 10.1016/j.contraception.2015.03.013. Epub 2015 Mar 27.

11.

Canadian demand for highly qualified personnel for therapeutic evaluation: an opportunity for academic institutions.

MacLeod SM, Soon JA, Sharma S, Wiens MO.

J Popul Ther Clin Pharmacol. 2014;21(3):e379-86. Epub 2014 Oct 19.

PMID:
25347149
12.

Post-market drug evaluation research training capacity in Canada: an environmental scan of Canadian educational institutions.

Wiens MO, Soon JA, MacLeod SM, Sharma S, Patel A.

J Popul Ther Clin Pharmacol. 2014;21(3):e370-8. Epub 2014 Oct 19.

PMID:
25347114
13.

What proportion of Canadian women will accept an intrauterine contraceptive at the time of second trimester abortion? Baseline data from a randomized controlled trial.

Norman WV, Brooks M, Brant R, Soon JA, Majdzadeh A, Kaczorowski J.

J Obstet Gynaecol Can. 2014 Jan;36(1):51-59. doi: 10.1016/S1701-2163(15)30683-6.

PMID:
24444287
14.

The perspective of rural physicians providing abortion in Canada: qualitative findings of the BC Abortion Providers Survey (BCAPS).

Dressler J, Maughn N, Soon JA, Norman WV.

PLoS One. 2013 Jun 28;8(6):e67070. doi: 10.1371/journal.pone.0067070. Print 2013.

15.

Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS).

Norman WV, Soon JA, Maughn N, Dressler J.

PLoS One. 2013 Jun 28;8(6):e67023. doi: 10.1371/journal.pone.0067023. Print 2013.

16.

Measuring and reporting of the treatment effect of hormonal emergency contraceptives.

Leung VW, Soon JA, Levine M.

Pharmacotherapy. 2012 Mar;32(3):210-21. doi: 10.1002/j.1875-9114.2012.01041.x. Review.

PMID:
22392454
17.

Rural pharmacy in Canada: pharmacist training, workforce capacity and research partnerships.

Soon JA, Levine M.

Int J Circumpolar Health. 2011 Sep;70(4):407-18. Epub 2011 Sep 16.

PMID:
21924009
18.

Immediate vs. delayed insertion of intrauterine contraception after second trimester abortion: study protocol for a randomized controlled trial.

Norman WV, Kaczorowski J, Soon JA, Brant R, Bryan S, Trouton KJ, Dicus L.

Trials. 2011 Jun 14;12:149. doi: 10.1186/1745-6215-12-149.

19.

Mechanisms of action of hormonal emergency contraceptives.

Leung VW, Levine M, Soon JA.

Pharmacotherapy. 2010 Feb;30(2):158-68. doi: 10.1592/phco.30.2.158. Review.

PMID:
20099990
20.

An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment.

McTaggart-Cowan HM, Shi P, Fitzgerald JM, Anis AH, Kopec JA, Bai TR, Soon JA, Lynd LD.

J Asthma. 2008 Oct;45(8):630-8. doi: 10.1080/02770900802126990.

PMID:
18951253
21.

Modelling costs and outcomes of expanded availability of emergency contraceptive use in British Columbia.

Soon JA, Meckley LM, Levine M, Marciante KD, Fielding DW, Ensom MH.

Can J Clin Pharmacol. 2007 Fall;14(3):e326-38. Epub 2007 Nov 30.

PMID:
18180535
22.

Emergency contraception update: a Canadian perspective.

Leung VW, Soon JA, Levine M.

Clin Pharmacol Ther. 2008 Jan;83(1):177-80. Epub 2007 Nov 28.

PMID:
18043681
23.

Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis.

Marra CA, Cibere J, Tsuyuki RT, Soon JA, Esdaile JM, Gastonguay L, Oteng B, Embley P, Colley L, Enenajor G, Kok R.

Arthritis Rheum. 2007 Oct 15;57(7):1238-44.

24.

Disparity between physical capacity and participation in seniors with chronic disease.

Ashe MC, Eng JJ, Miller WC, Soon JA.

Med Sci Sports Exerc. 2007 Jul;39(7):1139-46.

25.

Identifying barriers to emergency contraception use among young women from various sociocultural groups in British Columbia, Canada.

Shoveller J, Chabot C, Soon JA, Levine M.

Perspect Sex Reprod Health. 2007 Mar;39(1):13-20.

PMID:
17355377
26.

Risk of pregnancy among women seeking emergency contraceptives from pharmacists in British Columbia.

Levine M, Soon JA.

J Obstet Gynaecol Can. 2006 Oct;28(10):879-883. doi: 10.1016/S1701-2163(16)32276-9.

PMID:
17140503
27.

Outcomes of bupropion therapy for smoking cessation during routine clinical use.

Paluck EC, McCormack JP, Ensom MH, Levine M, Soon JA, Fielding DW.

Ann Pharmacother. 2006 Feb;40(2):185-90. Epub 2006 Jan 24.

PMID:
16434561
28.

Effects of making emergency contraception available without a physician's prescription: a population-based study.

Soon JA, Levine M, Osmond BL, Ensom MH, Fielding DW.

CMAJ. 2005 Mar 29;172(7):878-83. Erratum in: CMAJ. 2005 Apr 26;172(9):1164.

29.
30.

Effects of drug therapy on oral health of older adults.

Soon JA.

Probe. 1992 Autumn;26(3):118-20. No abstract available.

PMID:
1292028
31.

Assessment of an adverse drug reaction monitoring program in nursing homes.

Soon JA.

Can J Hosp Pharm. 1985 Aug;38(4):120-5.

PMID:
10274971
32.

Drug usage review. Part three: implementing the long-term care program.

Danforth DH, Hlynka JN, Soon JA.

Can Pharm J. 1982 Jan;115(1):9-12, 31. No abstract available.

PMID:
10254067
33.

Developing an adverse drug reaction program in nursing homes.

Soon JA.

Can J Hosp Pharm. 1980 Sep-Oct;33(5):158-61, 164.

PMID:
10249334
34.

Adverse drug reactions: why should they be reported?

Golightly LK, Hall DJ, Kane G, Soon JA.

Can J Hosp Pharm. 1979 May-Jun;32(3):71-2. No abstract available.

PMID:
10242858

Supplemental Content

Support Center